Early Aggregation of Amyloid-β(1-42) Studied by Fluorescence Correlation Spectroscopy

Area of Science:

• Neuroscience
• Biochemistry
• Biophysics

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder linked to Amyloid-β (Aβ) peptide aggregation.
• Early-stage soluble Aβ oligomers are implicated as key toxic species in AD pathogenesis.
• Characterizing Aβ aggregation is crucial for understanding AD development.

Purpose of the Study:

• To employ fluorescence correlation spectroscopy (FCS) for studying the early aggregation process of Aβ(1-42).
• To estimate the critical concentration for Aβ oligomer formation.
• To characterize the nature of early-stage Aβ aggregates.

Main Methods:

• Utilizing fluorescence correlation spectroscopy (FCS) to monitor terminally labeled Aβ in solution.
• Employing single-molecule resolution to detect changes in Aβ size and concentration.
• Analyzing freely diffusing fluorescently labeled Aβ species.

Main Results:

• FCS successfully monitored the early aggregation of Aβ(1-42) in solution.
• The study demonstrated the ability to estimate the critical concentration for oligomer formation.
• Characterization of the formed Aβ aggregates was achieved using FCS.

Conclusions:

• Fluorescence correlation spectroscopy is a valuable tool for studying Aβ aggregation dynamics in solution.
• FCS enables the characterization of early-stage Aβ oligomers, crucial for AD research.
• This approach provides insights into the critical concentration and nature of toxic Aβ aggregates.